Pdt Partners, LLC Vanda Pharmaceuticals Inc. Transaction History

Pdt Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $246,785 - $319,064	39,933 New	39,933 $271,000
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $195,804 - $243,925	-20,742 Reduced 50.83%	20,065 $198,000
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $167,831 - $213,439	18,027 Added 79.14%	40,807 $445,000
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $111,890 - $170,829	10,322 Added 82.85%	22,780 $258,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $195,466 - $263,362	12,458 New	12,458 $195,000
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $890,269 - $1.23 Million	-57,998 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $15,772 - $21,596	1,004 Added 1.76%	57,998 $1.25 Million
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $148,062 - $223,749	11,033 Added 24.01%	56,994 $856,000
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $348,193 - $492,174	-35,639 Reduced 43.68%	45,961 $604,000
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $148,635 - $191,694	-15,948 Reduced 16.35%	81,600 $788,000
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $651,199 - $810,292	67,412 Added 223.69%	97,548 $1.12 Million
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $226,020 - $506,284	30,136 New	30,136 $312,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.